Doumet Georges Helou

Sep 1, 2023 | mdpi.com | Bruno Crestani |Doumet Georges Helou |Deepak Pokhreal |Doumet Georges

1. Introduction 1.1. Generalities about IPF IPF is a fatal lung disease characterized by irreversible fibrosis of the lungs, leading to increased cough, dyspnea, and decreased quality of life. It is seen among middle-aged and elderly adults [1,2]. The incidence of IPF ranges from 0.09 to 1.30 per 10,000 persons globally, and the prevalence of the disease ranges from 0.33 to 4.51 per 10,000 persons [1].